Article
Serum fructosamine and glycemic status in the presence of the sickle cell mutation.
Diabetes research and clinical practice - 1 Jul 2021
Doumatey Ayo P, Feron Hermon, Ekoru Kenneth, Zhou Jie, Adeyemo Adebowale, Rotimi Charles N
Abstract excerpt
AIMS: The glycated hemoglobin (HbA1c) test can be unreliable in the presence of hemoglobinopathies. The co-existence of type 2 diabetes (T2D) with sickle cell anemia calls for alternative tests. Therefore, we established a reference interval for serum fructosamine and evaluated its utility as a potential glycemic biomarker that is not affected by abnormal hemoglobin. METHODS: The accuracies of serum fructosamine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.